Randomized Trialhigh evidence
Once-Weekly Semaglutide in Adults With Daily Cigarette Use: A Randomized Clinical Trial.
JAMA network open·May 1, 2026·PMID 42189538
Why it mattersSmokers face high cardiometabolic risk, and current cessation aids often cause weight gain. This trial provides early clinical evidence that semaglutide may reduce craving and weight, offering a dual-benefit approach that warrants further study in treatment-seeking populations.
The papers that matter, first.
MedLit ranks the medical literature into a specialty feed with concise summaries, evidence-aware triage, and visual takeaways.
§
MedLit · Evidence, Distilled